Revision of prices in Government Supply Contracts resulting from the war in Ukraine
The Department of Contracts (“DOC”) has published a second circular (the “Supply Guidelines”) which guides a contractor in filing a claim for compensation arising out of the Ukrainian conflict where the public contract in question has a supply element. It is important to note that the wording used by DOC’s Supply Guidelines is not limited to public …
Repeal of Companies Act (Public Companies – Annual General Meetings) Regulations
The Companies Act (Public Companies – Annual General Meetings) Regulations (the “Original Regulations”) were promulgated during the COVID-19 pandemic to (1) extend the period for holding of annual general meetings, and filing of audited accounts; and (2) authorise the holding of remote or virtual general meetings by certain public companies.
Juridical interest in the context of insurance claims
On the 22 June 2022, in the case of ‘A. Pace Balzan v Citadel Insurance p.l.c.’, the Court of Appeal in its inferior jurisdiction, presided over by Judge Lawrence Mintoff, delved into the concept of juridical interest in the context of an insurance claim.
Practical Advice on Unilateral Change of Position and Salary by Employer in China
After the execution of employment contract, employer may sometimes need to change an employee’s position and salary for various reasons. Such a change may be a “bilateral” one which means both the employer and the employee particularly agreed on the conditions of such an individual change, or it could be a “unilateral” one which means …
Continue reading “Practical Advice on Unilateral Change of Position and Salary by Employer in China”
Wolf Pack Activism vs. Poison Pill in Japan
On July 28, 2022, the Japan Supreme Court upheld the decision of the Tokyo High Court to halt the implementation of the shareholders’ rights plan (or poison pill) of Mitsuboshi[1] that was challenged by one of its shareholders, Adage Capital (“Adage”). It was the first court case in Japan where a listed company implemented a …
Continue reading “Wolf Pack Activism vs. Poison Pill in Japan”
A Commentary on the System of Calling for Third-Party Comments (From the Perspective of a Drafter of the Bill)
I joined Oh-Ebashi LPC & Partners after serving as a Senior Specialist for Legislation at the Legislative Affairs Office of the Japan Patent Office (“JPO”) for three years. One of my accomplishments during my time at the JPO was being involved in drafting the bill to amend the Patent Act of Japan (the “Patent Act”). …
Stablecoins Regulations in Japan
The Financial Services Agency (“FSA”) established a Working Group on Payment Services, and the report of this working group (“Report”) was published on January 11, 2022. In response to the Report, amendments to the Payment Services Act (“PSA”),[1] the Act on Prevention of Transfer of Criminal Proceeds, Financial Instruments and Exchange Act (“FIEA”),[2] the Banking …
Legal Compliance of Workplace Surveillance in China – From a Personal Information Protection Perspective
A few months ago, a piece of rather interesting news in China raised debates about to what extent an employer can impose surveillance upon its employees in workplaces. The news reported that one major e-commerce company in China has internally announced sanctions upon some of its employees on the ground of excessive access to work-irrelevant …
China’s Life Sciences and Healthcare-No.2 – The Good Vigilance Practice rule in China
This article will introduce the drug vigilance activities required by the new Good Vigilance Practice (“GVP”), enacted on May 7, 2021, and come into effect on December 1, 2021. The GVP will be applied to MAHs and NDA applicants conducting clinical trials.
Private Client – Lexology Getting The Deal Through – Cyprus
Stella Strati and Nikoleta Christofidi contribute the Cyprus chapter to GTDT’s Private Client Guide.